UNSPSC 85522158: Bypass left subclavian vein to upper vein with autologous arterial tissue, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left subclavian vein to upper vein with autologous arterial tissue, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05164AY

UNSPSC 85522158 Bypass left subclavian vein to upper vein with autologous arterial tissue, percutaneous endoscopic approach (Commodity) shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific surgical procedure, yet the recent opportunities tagged under it span occupational medical surveillance, independent disability evaluations, pharmacy benefit management, temporary health professional staffing, and surgical benefit carve-out programs — none of which involve the vascular bypass procedure the code names. This mismatch suggests either miscoding in the source data or that state and local procurement offices are using the code as a catch-all health services category rather than for the specific procedure indicated.

The issuing bodies in the recent activity include a state department (Washington State Department of Transportation), multiple cities (Phoenix, Long Beach), a county government (Collier County, Harris County, Santa Clara County), and a county health system (Santa Clara). Geographic spread covers Washington, Arizona, California, Texas, and Florida. Representative recent opportunities include the Washington State Department of Transportation's RFP for occupational medical surveillance services for ferry workers (due October 9, 2026, with pre-bid August 31), the City of Phoenix's RFP for independent medical evaluation services for pension boards (due October 16, 2026), and Collier County's RFP for pharmacy benefit management services (due April 9, 2026, with historical annual spending of approximately $8.7 million). Given the disconnect between the code's nominal scope and the work actually being solicited, this code presents limited decision-relevance for vendors pursuing vascular surgical procedures or related implant and device work in state and local markets.